Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy. 2021

Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
Department of Ophthalmology, Boston University School of Medicine & Boston Medical Center, Boston, MA 02118, USA.

In this study, we compare the vitreous cytokine profile in patients with proliferative diabetic retinopathy (PDR) to that of patients without PDR. The identification of novel cytokines involved in the pathogenesis of PDR provides candidate therapeutic targets that may stand alone or work synergistically with current therapies in the management of diabetic retinopathy. Undiluted vitreous humor specimens were collected from 74 patients undergoing vitrectomy for various vitreoretinal disorders. Quantitative immunoassay was performed for a panel of 36 neuroinflammatory cytokines in each specimen and assessed to identify differences between PDR (n = 35) and non-PDR (n = 39) patients. Levels of interleukin-8 (IL-8), IL-15, IL-16, vascular endothelial growth factor (VEGF), VEGF-D, c-reactive protein (CRP), serum amyloid-A (SAA), and intracellular adhesion molecule-1 (ICAM1) were significantly increased in the vitreous of PDR patients compared to non-PDR patients (p < 0.05). We report novel increases in IL-15 and IL-16, in addition to the expected VEGF, in the human vitreous humor of patients with PDR. Additionally, we confirm the elevation of ICAM-1, VCAM-1, SAA, IL-8 and CRP in the vitreous of patients with PDR, which has previously been described.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014822 Vitreous Body The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe. Vitreous Humor,Bodies, Vitreous,Body, Vitreous,Humor, Vitreous,Humors, Vitreous,Vitreous Bodies,Vitreous Humors
D016222 Fibroblast Growth Factor 2 A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 1). Basic Fibroblast Growth Factor,Fibroblast Growth Factor, Basic,HBGF-2,Cartilage-Derived Growth Factor,Class II Heparin-Binding Growth Factor,FGF-2,FGF2,Fibroblast Growth Factor-2,Heparin-Binding Growth Factor Class II,Prostate Epithelial Cell Growth Factor,Prostatropin,Cartilage Derived Growth Factor,FGF 2
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular

Related Publications

Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
February 2020, Investigative ophthalmology & visual science,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
April 2008, Ophthalmology,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
May 2012, The British journal of ophthalmology,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
December 1965, Archives of ophthalmology (Chicago, Ill. : 1960),
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
June 1994, Investigative ophthalmology & visual science,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
January 2016, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
September 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
July 2000, American journal of ophthalmology,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
September 2019, Diabetes research and clinical practice,
Dean F Loporchio, and Emily K Tam, and Jane Cho, and Jaeyoon Chung, and Gyungah R Jun, and Weiming Xia, and Marissa G Fiorello, and Nicole H Siegel, and Steven Ness, and Thor D Stein, and Manju L Subramanian
January 1996, Ophthalmic research,
Copied contents to your clipboard!